These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 22843930)
1. Decreased immunoexpression of standard form of CD44 is an independent favourable predictor of nodal metastasis in colorectal carcinoma. Al-Maghrabi J; Gomaa W; Buhmeida A; Al-Qahtani M; Al-Ahwal M Anticancer Res; 2012 Aug; 32(8):3455-61. PubMed ID: 22843930 [TBL] [Abstract][Full Text] [Related]
2. Expression of standard CD44 in human colorectal carcinoma: association with prognosis. Huh JW; Kim HR; Kim YJ; Lee JH; Park YS; Cho SH; Joo JK Pathol Int; 2009 Apr; 59(4):241-6. PubMed ID: 19351367 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of CD44 expression in colorectal carcinomas. Sökmen S; Lebe B; Sarioglu S; Füzün M; Terzi C; Küpelioglu A; Ellidokuz H Anticancer Res; 2001; 21(6A):4121-6. PubMed ID: 11911305 [TBL] [Abstract][Full Text] [Related]
4. Comparison of CD44 expression in primary tumours and metastases of colorectal cancer. Bendardaf R; Algars A; Elzagheid A; Korkeila E; Ristamäki R; Lamlum H; Collan Y; Syrjänen K; Pyrhönen S Oncol Rep; 2006 Oct; 16(4):741-6. PubMed ID: 16969488 [TBL] [Abstract][Full Text] [Related]
5. Reduced CD44 standard expression is associated with tumour recurrence and unfavourable outcome in differentiated thyroid carcinoma. Böhm JP; Niskanen LK; Pirinen RT; Kiraly K; Kellokoski JK; Moisio KI; Eskelinen MJ; Tulla HE; Hollmen S; Alhava EM; Kosma VM J Pathol; 2000 Nov; 192(3):321-7. PubMed ID: 11054715 [TBL] [Abstract][Full Text] [Related]
6. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis. Joo M; Lee HK; Kang YK Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426 [TBL] [Abstract][Full Text] [Related]
7. Expression of cell adhesion molecules, CD44s and E-cadherin, and microvessel density in invasive micropapillary carcinoma of the breast. Gong Y; Sun X; Huo L; Wiley EL; Rao MS Histopathology; 2005 Jan; 46(1):24-30. PubMed ID: 15656882 [TBL] [Abstract][Full Text] [Related]
8. Role and prognostic significance of CD44s expression in colorectal cancer. Visca P; Del Nonno F; Botti C; Marandino F; Sebastiani V; Di Tondo U; Donnorso RP; Trombetta G; Filippi S; Alo PL Anticancer Res; 2002; 22(5):2671-5. PubMed ID: 12529980 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of risk of liver metastasis in colorectal adenocarcinoma based on the combination of risk factors including CD10 expression: multivariate analysis of clinicopathological and immunohistochemical factors. Ohji Y; Yao T; Eguchi T; Yamada T; Hirahashi M; Iida M; Tsuneyoshi M Oncol Rep; 2007 Mar; 17(3):525-30. PubMed ID: 17273728 [TBL] [Abstract][Full Text] [Related]
10. Expression of the hyaluronan receptor, CD44S, in epithelial ovarian cancer is an independent predictor of survival. Kayastha S; Freedman AN; Piver MS; Mukkamalla J; Romero-Guittierez M; Werness BA Clin Cancer Res; 1999 May; 5(5):1073-6. PubMed ID: 10353740 [TBL] [Abstract][Full Text] [Related]
11. Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer. Yamamoto H; Iku S; Adachi Y; Imsumran A; Taniguchi H; Nosho K; Min Y; Horiuchi S; Yoshida M; Itoh F; Imai K J Pathol; 2003 Feb; 199(2):176-84. PubMed ID: 12533830 [TBL] [Abstract][Full Text] [Related]
12. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739 [TBL] [Abstract][Full Text] [Related]
13. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance. Nguyen VN; Mirejovský T; Melinová L; Mandys V Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866 [TBL] [Abstract][Full Text] [Related]
15. Expression of clusterin in colorectal carcinoma in relation to clinicopathological criteria. Gomaa W; Al-Ahwal M; Al-Maghrabi H; Buhmeida A; Al-Qahtani M; Al-Maghrabi B; Al-Maghrabi J Malays J Pathol; 2017 Dec; 39(3):243-250. PubMed ID: 29279586 [TBL] [Abstract][Full Text] [Related]
16. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy. Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753 [TBL] [Abstract][Full Text] [Related]
17. Decreased CD44 standard form expression correlates with prognostic variables in ovarian carcinomas. Ross JS; Sheehan CE; Williams SS; Malfetano JH; Szyfelbein WM; Kallakury BV Am J Clin Pathol; 2001 Jul; 116(1):122-8. PubMed ID: 11447742 [TBL] [Abstract][Full Text] [Related]
18. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer. Friedrichs K; Franke F; Lisboa BW; Kügler G; Gille I; Terpe HJ; Hölzel F; Maass H; Günthert U Cancer Res; 1995 Nov; 55(22):5424-33. PubMed ID: 7585612 [TBL] [Abstract][Full Text] [Related]
19. nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver. Sarris M; Lee CS Eur J Surg Oncol; 2001 Mar; 27(2):170-4. PubMed ID: 11289754 [TBL] [Abstract][Full Text] [Related]
20. CD44s expression mitigates the phenotype of human colorectal cancer hepatic metastases. Pereira PA; Rubenthiran U; Kaneko M; Jothy S; Smith AJ Anticancer Res; 2001; 21(4A):2713-7. PubMed ID: 11724345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]